More on SLDB
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $8.72 |
|
|||
| Open | $8.72 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $8.72 | ||||
| Day Low | $8.72 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 22 | ||||
- Solid Biosciences (SLDB) Reiterated at Overweight by Cantor Fitzgerald, Stock a 'Top Pick'
- RBC Capital Starts Solid Biosciences (SLDB) at Outperform
- H.C. Wainwright Reiterates Buy Rating on Solid Biosciences (SLDB)
- Solid Biosciences to Participate at Upcoming Investor Conferences
- Solid Biosciences (SLDB) PT Raised to $26 at Cantor Fitzgerald Before INSPIRE Ph1/2 Readout
- Truist Securities Assumes Solid Biosciences (SLDB) at Buy
- Form SCHEDULE 13D/A Solid Biosciences Inc. Filed by: PERCEPTIVE ADVISORS LLC
- Form SCHEDULE 13G/A Solid Biosciences Inc. Filed by: Vestal Point Capital, LP
- Solid Biosciences (SLDB) Reiterated at Market Outperform by Citizens on Continued Execution
- Solid Biosciences (SLDB) Tops Q2 EPS by 7c
Entities mentioned with SLDB
- FDA | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- Chardan Capital Markets | View Related Stories »
- Show More...
